Tricyclic compounds useful as inhibitors of kinases
US8518964B2 · kind B2 · utility
41Cited by
4References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 17, 2006 |
| Grant date | Aug 27, 2013 |
| Priority date | — |
| Expiry date | Oct 4, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides inhibitors of kinases, specifically IκB kinases, JAK1, JAK2, JAK3 and TYK2. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting said kinase activity by administering the compound to a patient in need of treatment for myeloproliferative disorders, cancer or NF-κB-mediated diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.